Jenny C. Chang

Best Publications

• Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy

  Xiaoxian Li;Michael T. Lewis;Jian Huang;Carolina Gutierrez

  2169
  Citations

• Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

  Chad J. Creighton;Xiaoxian Li;Melissa Landis;J. Michael Dixon

  1590
  Citations

• Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer

  Matthew D. Burstein;Anna Tsimelzon;Graham M. Poage;Kyle R. Covington

  1251
  Citations

• Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts

  Suling Liu;Yang Cong;Dong Wang;Yu-Min Sun

  1171
  Citations

• Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

  Trevor Powles;Ros Eeles;Sue Ashley;Doug Easton

  1168
  Citations

• Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

  Jenny C. Chang;Eric C. Wooten;Anna Tsimelzon;Susan G. Hilsenbeck

  1090
  Citations

• XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway

  Xi Chen;Dimitrios Iliopoulos;Dimitrios Iliopoulos;Qing Zhang;Qianzi Tang;Qianzi Tang

  924
  Citations

• Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase

  Joan T. Garrett;María Graciela Olivares;Cammie Rinehart;Nara D. Granja-Ingram

  508
  Citations

• A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models

  Xiaomei Zhang;Sofie Claerhout;Aleix Prat;Lacey E. Dobrolecki

  496
  Citations

• Regulators of Mitotic Arrest and Ceramide Metabolism Are Determinants of Sensitivity to Paclitaxel and Other Chemotherapeutic Drugs

  Charles Swanton;Michela Marani;Olivier Pardo;Patricia H. Warne

  449
  Citations

• A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer

  A. Makris;T. J. Powles;S. E. Ashley;Jenny C. Chang

  445
  Citations

• Cancer stem cells: Role in tumor growth, recurrence, metastasis, and treatment resistance.

  Jenny C. Chang

  418
  Citations

• Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.

  Jenny Chang;Gary M. Clark;D. Craig Allred;Syed Mohsin

  372
  Citations

• Microenvironmental Regulation of Epithelial–Mesenchymal Transitions in Cancer

  Dingcheng Gao;Linda T. Vahdat;Stephen T. Wong;Jenny C. Chang

  368
  Citations

• Loss of Phosphatase and Tensin Homolog or Phosphoinositol-3 Kinase Activation and Response to Trastuzumab or Lapatinib in Human Epidermal Growth Factor Receptor 2–Overexpressing Locally Advanced Breast Cancers

  Bhuvanesh Dave;Ilenia Migliaccio;M. Carolina Gutierrez;Meng Fen Wu

  330
  Citations

• Multicenter Phase II Study of Neoadjuvant Lapatinib and Trastuzumab With Hormonal Therapy and Without Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: TBCRC 006

  Mothaffar F. Rimawi;Ingrid A. Mayer;Andres Forero;Rita Nanda

  328
  Citations

• Biologic Markers as Predictors of Clinical Outcome From Systemic Therapy for Primary Operable Breast Cancer

  Jenny C. Chang;T. J. Powles;D. C. Allred;S. E. Ashley

  326
  Citations

• Epithelial-mesenchymal transition, cancer stem cells and treatment resistance

  Bhuvanesh Dave;Vivek Mittal;Nicholas M Tan;Jenny C Chang

  319
  Citations

• Neoadjuvant Trastuzumab Induces Apoptosis in Primary Breast Cancers

  Syed K. Mohsin;Heidi L. Weiss;M. Carolina Gutierrez;Gary C. Chamness

  301
  Citations

• Epithelial-Mesenchymal Transition (EMT) in Tumor-Initiating Cells and Its Clinical Implications in Breast Cancer

  Chad J. Creighton;Jenny C. Chang;Jeffrey M. Rosen

  293
  Citations